pathway_id,pathway_term,pathway_source,proteins
hsa05034,Alcoholism,KEGG,HDAC6;HDAC5;ADORA2B;CREB1;DRD2;SLC29A1;FOSB;SHC2;GNAI1;GNAI2;GNAI3;GNAS;GNB1;GNB2;GNB3;GNG4;GNG5;GNG7;GNG11;GRB2;GRIN2A;HIST1H2AD;H2AFX;H2AFZ;HIST1H2BD;HIST1H2BB;H3F3A;HDAC1;HDAC2;KRAS;MAOA;MAOB;ATF4;NRAS;NTRK2;HDAC7;PPP1CA;PPP1CB;PPP1CC;H2AFY2;PRKACA;PKIA;H2AFJ;HDAC8;MAPK1;MAPK3;MAP2K1;RAF1;BDNF;SLC18A2;SOS1;SOS2;TH;HIST2H2AA3;CALM2;CALM3;HIST1H2AC;HIST1H2BH;HIST1H2BC;HIST2H2BE;HIST1H3D;HIST1H4A;HIST1H2BK;HDAC3;HIST1H2AG;CREB3L1;CALML4;HIST3H2A;H2AFV;H2AFY;CREB5;HDAC9;HDAC4
hsa05203,"Viral carcinogenesis",KEGG,HDAC6;HDAC5;CDK2;CDK4;CDK6;CDKN1A;CDKN1B;CDKN2B;IRF9;GTF2A1L;CHD4;CHEK1;CREB1;CREBBP;DDX3X;DLG1;EGR2;EGR3;EP300;UBR4;GRB2;MRPS18B;GTF2A1;GTF2A2;GTF2B;GTF2H1;GTF2H2;GTF2H4;HIST1H2BD;HIST1H2BB;HDAC1;HDAC2;HLA-A;HLA-B;HLA-C;HLA-E;HLA-F;HLA-G;IL6ST;JAK1;JAK3;JUN;KRAS;RHOA;LTBR;LYN;MDM2;ATF4;NFKB1;NRAS;HDAC7;PIK3CA;PIK3CB;PIK3CD;PIK3R1;PKM;PMAIP1;PRKACA;HDAC8;MAPK1;MAPK3;PSMC1;BAD;BAX;RAC1;RANBP1;RASA2;RB1;RBL1;REL;RELA;SKP2;SP100;STAT3;STAT5A;STAT5B;SYK;TP53;C3;TRAF1;GTF2H2C_2;VDAC3;YWHAB;YWHAE;YWHAH;YWHAZ;ACTN4;HIST1H2BH;HIST1H2BC;HIST2H2BE;HIST1H4A;MAD1L1;CASP8;HIST1H2BK;ACTN1;TRADD;HDAC3;KAT2B;CCNA2;CCNA1;CCND2;CCND3;CREB3L1;ATP6V0D1;CCNE2;MAPKAPK2;CREB5;HDAC9;HDAC4;CDK1;CDC20;CDC42
hsa05322,"Systemic lupus erythematosus",KEGG,FCGR1A;FCGR2A;FCGR3B;GRIN2A;HIST1H2AD;H2AFX;H2AFZ;HIST1H2BD;HIST1H2BB;H3F3A;HLA-DMA;HLA-DMB;HLA-DOB;HLA-DPA1;HLA-DQA1;HLA-DQA2;HLA-DQB1;HLA-DRA;HLA-DRB1;HLA-DRB3;HLA-DRB4;HLA-DRB5;IL10;H2AFY2;H2AFJ;SNRPB;SNRPD1;SNRPD3;TROVE2;SSB;C1QA;TNF;C1R;C1S;C3;C4A;C4B;HIST2H2AA3;C6;C7;C8G;ACTN4;HIST1H2AC;HIST1H2BH;HIST1H2BC;HIST2H2BE;HIST1H3D;HIST1H4A;HIST1H2BK;ACTN1;HIST1H2AG;HIST3H2A;CD28;H2AFV;H2AFY;CD40LG